AG

Artal Group Portfolio holdings

AUM $930M
This Quarter Return
+2.75%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$2.17B
AUM Growth
+$2.17B
Cap. Flow
+$155M
Cap. Flow %
7.14%
Top 10 Hldgs %
58.3%
Holding
120
New
20
Increased
21
Reduced
32
Closed
19

Top Buys

1
AVTR icon
Avantor
AVTR
$134M
2
Z icon
Zillow
Z
$41.8M
3
UBER icon
Uber
UBER
$23.2M
4
CYCN icon
Cyclerion Therapeutics
CYCN
$15.6M
5
CHNG
Change Healthcare Inc. Common Stock
CHNG
$11M

Top Sells

1
ARRY
Array Biopharma Inc
ARRY
$48.8M
2
IFRX icon
InflaRx
IFRX
$31.2M
3
ZGNX
Zogenix, Inc.
ZGNX
$11M
4
WVE icon
Wave Life Sciences
WVE
$9.71M
5
BPMC
Blueprint Medicines
BPMC
$9.43M

Sector Composition

1 Healthcare 72.1%
2 Consumer Discretionary 17.9%
3 Technology 5.46%
4 Communication Services 2.13%
5 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
IOVA icon
26
Iovance Biotherapeutics
IOVA
$807M
$17.2M 0.69% 700,000 +200,000 +40% +$4.9M
DRNA
27
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$15.8M 0.64% 1,000,000 +20,725 +2% +$326K
CYCN icon
28
Cyclerion Therapeutics
CYCN
$7.91M
$15.6M 0.63% +1,361,584 New +$15.6M
MRTX
29
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$15.5M 0.62% 150,000 -25,000 -14% -$2.58M
ALBO
30
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
$14.5M 0.59% 450,000 -50,000 -10% -$1.61M
TCDA
31
DELISTED
Tricida, Inc. Common Stock
TCDA
$14.2M 0.57% 360,000 +135,000 +60% +$5.33M
BOLD
32
DELISTED
Audentes Therapeutics, Inc
BOLD
$13.3M 0.54% 350,000 -50,000 -13% -$1.89M
BLUE
33
DELISTED
bluebird bio
BLUE
$12.7M 0.51% 100,000 – –
HTHT icon
34
Huazhu Hotels Group
HTHT
$11.3B
$12.7M 0.51% 350,000 +200,000 +133% +$7.25M
NIO icon
35
NIO
NIO
$14.3B
$12.4M 0.5% 4,850,000 +250,000 +5% +$638K
KRYS icon
36
Krystal Biotech
KRYS
$4.27B
$12.1M 0.49% 300,000 – –
PRQR icon
37
ProQR Therapeutics
PRQR
$237M
$11.8M 0.48% 1,300,000 -100,000 -7% -$910K
XNCR icon
38
Xencor
XNCR
$580M
$11.3M 0.46% 275,000 -225,000 -45% -$9.21M
CHNG
39
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$11M 0.44% +750,000 New +$11M
KLDO
40
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$10.4M 0.42% 900,500 -46,919 -5% -$544K
AXDX
41
DELISTED
Accelerate Diagnostics
AXDX
$10.3M 0.42% 450,000 -50,000 -10% -$1.14M
ALDR
42
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
$10M 0.4% 850,000 +350,000 +70% +$4.12M
MORF
43
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$9.91M 0.4% +500,000 New +$9.91M
ADPT icon
44
Adaptive Biotechnologies
ADPT
$2.01B
$9.66M 0.39% +200,000 New +$9.66M
TBIO
45
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$9.47M 0.38% 750,000 +150,000 +25% +$1.89M
YMAB icon
46
Y-mAbs Therapeutics
YMAB
$388M
$9.15M 0.37% +400,000 New +$9.15M
STNE icon
47
StoneCo
STNE
$4.41B
$8.87M 0.36% +300,000 New +$8.87M
REPL icon
48
Replimune Group
REPL
$422M
$8.8M 0.36% 600,000 – –
DNLI icon
49
Denali Therapeutics
DNLI
$2.23B
$8.3M 0.34% 400,000 – –
TPTX
50
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$8.14M 0.33% +200,000 New +$8.14M
1
2
3 4 5